A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial malignant protector protein is frequently lost in many types of malignancies, https://pukkabookmarks.com/story22000513/nanobodies-revive-tumor-suppressor-p53-a-new-hope-for-tumor-management